Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 4 hours ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 1 hour agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology. The complaint relates to patents discovered by researchers who ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 23 hours agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 2 days agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer Shareholders Reject Political Spending, Lobbying Proposal
Bloomberg Law· 4 hours agoPfizer investors dismissed a proposal that would have required the drugmaker to disclose how its political donations square with its publicly stated values, at the company ...
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 minutes agoCureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 27 minutes agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 1 day agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...
